Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21270442 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Interventions: Drug: CEP-701;   Drug: high-dose cytarabine;   Drug: Mitozantrone, Etoposide, Cytarabine (combination Chemotherapy)

Indicates status has not been verified in more than two years